NovoCure Limited Ordinary Shares
NVCR •
Sell Closed
Signal type
Sell
Status
Closed
Open Price
$10.94
Closed Price
$11.30
Performance
-3.34%
Days Open
18
Signal Setup
Signal Type Sell
Status Closed
Open Date Mar 27, 2026
Open Price $10.94
Stop Loss $12.98
Timespan Day
Trade Outcome
Closed Status Loss
Closed Date Apr 14, 2026
Closed Price $11.30
Performance -3.34%
Days Open 18
Company Profile
Name NovoCure Limited Ordinary Shares
Ticker NVCR
Market Cap $1.99B
Sector SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Latest Close $11.30
List Date Oct 2, 2015
Description
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
Website Open Company Website